Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04390009 · ClinicalTrials.gov registry record · Early Phase 1
Entire-body PET Scans for Multiple Sclerosis
A Early Phase 1 study of Multiple Sclerosis, sponsored by Brain Health Alliance.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04390009 is a Early Phase 1 study of Multiple Sclerosis that is actively recruiting participants, run by Brain Health Alliance. The registered enrollment target is 20 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04390009, a Early Phase 1 study of Multiple Sclerosis, is actively recruiting participants, sponsored by Brain Health Alliance.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Entire-body PET-CT scans
- DRUG Amyvid radiopharmaceutical
Study Locations (1)
California
- Brain Health Alliance - Ladera Ranch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-30 |
| Est. Completion | 2025-12-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04390009
The ClinicalTrials.gov registry entry for NCT04390009 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Brain Health Alliance, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Entire-body PET-CT scans is the first listed.
NCT04390009 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04390009 about?
NCT04390009 is a clinical study titled "Entire-body PET Scans for Multiple Sclerosis". To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
What is the current status of trial NCT04390009?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2024-09-30. Estimated completion is 2025-12-30.
What conditions does trial NCT04390009 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT04390009?
The interventions under investigation include: Entire-body PET-CT scans (DIAGNOSTIC_TEST), Amyvid radiopharmaceutical (DRUG).
Who is sponsoring clinical trial NCT04390009?
This trial is sponsored by Brain Health Alliance, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04390009 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Assessment of Synaptic Density in MS
RECRUITING · Early Phase 1
-
Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis
ACTIVE NOT RECRUITING · Early Phase 1
-
Acute Effects of Walking Exercise on Brain Functioning in Multiple Sclerosis
ACTIVE NOT RECRUITING · Early Phase 1
-
Novel Imaging Markers in SPMS
COMPLETED · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.